IQVIA™ Real-World Insights Bibliography

Healthcare resource utilization and economic burden of antifungal management in patients with hematologic malignancy in Japan: a retrospective database study
Author(s): Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Dilinuer Ainiwaer 2 (rwesheorj 2)
Affiliations(s): 1) MSD K.K, Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan
Publication(s):  Current Medical Research and Opinion
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Infectious disease,
2021
  L:
A:
English
Database Study,
  Add to report
 
 
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publication(s):  IPVC, Barcelona, Spain, 23-27 March 2020
Document Type(s): Oral presentation,
Countries: China, France, Germany, Italy, Japan, Portugal, Spain,
C:
Y:
Infectious disease, Oncology,
2020
  L:
A:
English
Burden of illness, Observational study, Retrospective Field Study,
  Add to report
 
 
Clinical management of serious infections attributable to carbapenem-resistant Gram-negative pathogens in Spanish hospitals
Author(s): Ferrer R1, Calvo-Montes J2, Maseda E3, Salavert M4, Bou G5, Díaz-Regañón J6, López D6, Lozano V6, Gómez-Ulloa D7, Fenoll R7, Sánchez E7, McCann E8
Affiliations(s): 1 Vall d'Hebron University Hospital, Barcelona, Spain 2 Marqués de Valdecilla University Hospital, Santander, Spain 3 La Paz University Hospital, Madrid, Spain 4 La Fe University and Polytechnic Hospital, Valencia, Spain 5 La Coruña University Hospital, La Coruña, Spain, Spain 6 Merck Sharp & Dohme Corp., Madrid, Spain 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US
Publication(s):  ECCMID, Paris, France, 18-21 April 2020
Document Type(s): Poster,
Countries: Spain,
C:
Y:
Infectious disease,
2020
  L:
A:
English
Observational study, Retrospective Field Study,
  Add to report
 
 
Real-world treatment patterns observed in patients with carbapenem-resistant Gram-negative infections in Italian hospitals
Author(s): Durante Mangoni E1, Mastroianni C2, Viale P3, Bassetti M4, Citton R5, Fenoll R6, Roset M6, McCann E7
Affiliations(s): 1 University of Campania ?L. Vanvitelli?, Monaldi Hospital, Naples, Italy 2 Policlinico Umberto I, Rome, Italy 3 AOU Policlinico S. Orsola-Malpighi, Bologna, Italy 4 University of Genova and Ospedale Policlinico San Martino, Genova, Italy 5 RC Merck Sharp & Dohme, Rome, Italy 6 IQVIA, Barcelona, Spain 7 Merck & Co., Inc., Kenilworth, NJ, US
Publication(s):  ECCMID, Paris, France, 18-21 April 2020
Document Type(s): Oral presentation,
Countries: Italy,
C:
Y:
Infectious disease,
2020
  L:
A:
English
Observational study, Retrospective Field Study,
  Add to report
 
 
Real-world treatment of patients diagnosed with serious infections due to carbapenem-resistant Gram-negative pathogens in Greek hospitals
Author(s): Georgopoulos D1, Safarika A2, Ischaki E3, Filiou E4, Mantzarlis K5, Athanasopoulos D6, Fenoll R7, Sánchez E7, McCann E8
Affiliations(s): 1 University Hospital of Crete, Crete, Greece 2 National and Kapodistrian University of Athens, Athens, Greece 3 General Hospital of Athens Evaggelismos, Athens, Greece 4 National and Kapodistrian University of Athens, Medical School, General Hospital for Chest Diseases 'I Sotiria? , Athens, Greece 5 University Hospital of Larissa, Larissa, Greece 6 Merck Sharp & Dohme Corp., Athens, Greece 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US
Publication(s):  ECCMID, Paris, France, 18-21 April 2020
Document Type(s): Oral presentation,
Countries: Greece,
C:
Y:
Infectious disease,
2020
  L:
A:
English
Observational study, Retrospective Field Study,
  Add to report
 
 
Resource utilisation associated with infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals
Author(s): Durante Mangoni E1, Georgopoulos D2, Fernández-Martínez M3, Mastroianni C4, Viale P5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Perivoliotis E11 ,Bou Arevalo G12, Koutsoukou A13, Mantzarlis K14, Lozano V15, Gómez-Ulloa D16, Roset M16, McCann E17
Affiliations(s): 1 ‘L. Vanvitelli’ University, Monaldi Hospital, Naples, Italy 2 University Hospital of Crete, Crete, Greece 3 Marqués de Valdecilla University Hospital, Santander, Spain 4 Policlinico Umberto I, Rome, Italy 5 Policlinico S. Orsola-Malpighi, Bologna, Italy 6 University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’ , Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US
Publication(s):  ECCMID, Paris, France, 18-21 April 2020
Document Type(s): Oral presentation,
Countries: Greece, Italy, Spain,
C:
Y:
Infectious disease,
2020
  L:
A:
English
Observational study, Retrospective Field Study,
  Add to report
 
 
Outcomes and predictors of outcomes of serious infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals
Author(s): Georgopoulos D1, Durante Mangoni E2, Mastroianni C3, Viale P4, Arnáiz de las Revillas F5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Malachias S11, Bou Arevalo G12, Kyriakoudi A13, Tsolaki V14, Lopez D15, Gómez-Ulloa D16, Lara N16, McCann E17
Affiliations(s): 1 University Hospital of Crete, Crete, Greece 2 ‘L. Vanvitelli’, Monaldi Hospital, Naples, Italy 3 Policlinico Umberto I, Rome, Italy 4 Policlinico S. Orsola-Malpighi, Bologna, Italy 5 Marqués de Valdecilla University Hospital, Santander, Spain 6University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’, Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US
Publication(s):  ECCMID, Paris, France, 18-21 April 2020
Document Type(s): Oral presentation,
Countries: Greece, Italy, Spain,
C:
Y:
Infectious disease,
2020
  L:
A:
English
Observational study, Retrospective Field Study,
  Add to report
 
 
Infections in patients with multiple sclerosis: A national cohort study in Sweden
Author(s): Anna Castelo-Branco, Flaminia Chiesa, Simona Conte, Camilla Bengtsson , Sally Lee, Neil Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery
Affiliations(s): 1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA
Publication(s):  Mult Scler Relat Disord. 2020;45:102420. [published online ahead of print, 2020 Jul 23].
Document Type(s): Abstract,
Countries: Sweden,
Click here for the abstract
C:
Y:
Infectious disease, Neurological disorders, Patient Registries & Real-World Study Methods,
2020
  L:
A:
English
Epidemiological study,
  Add to report
 
 
Combatting COVID-19 With Real-World Evidence
Author(s): Jennifer B. Christian, PharmD, MPH, PhD , Matthew W. Reynolds, PhD
Affiliations(s): Jennifer B. Christian, PharmD, MPH, PhD, is vice president of Clinical Evidence & Epidemiology, Real World Solutions, IQVIA Matthew W. Reynolds, PhD, is vice president, Real World Evidence, IQVIA
Publication(s):  AJMC.org (UVPM: 137,786)
September 7, 2020 Jennifer B. Christian, PharmD, MPH, PhD , Matthew W. Reynolds, PhD
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Infectious disease,
2020
  L:
A:
English
Burden of illness, direct to patient research, Methodology,
  Add to report
 
 
The disease burden of mucormycosis in Japan: results from a systematic literature review and retrospective database study
Author(s): Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Dilinuer Ainiwaer 2 (rwesheorj 2)
Affiliations(s): 1) MSD KK, Tokyo, Japan 2) IQVIA Solutions Japan KK, Tokyo, Japan
Publication(s):  Current Medical Research and Opinion
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Infectious disease,
2020
  L:
A:
English
Database Study, Literature Review,
  Add to report
 
 
 1 of 15 Next Page Last Page